BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21394687)

  • 1. A survey on regenerative surgery performed by Swiss specialists in periodontology with special emphasis on the application of enamel matrix derivatives in infrabony defects.
    Schröen O; Sahrmann P; Roos M; Attin T; Schmidlin PR
    Schweiz Monatsschr Zahnmed; 2011; 121(2):136-42. PubMed ID: 21394687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethylene membranes in the treatment of infrabony defects: a comparative controlled clinical trial.
    Zucchelli G; Bernardi F; Montebugnoli L; De SM
    J Periodontol; 2002 Jan; 73(1):3-12. PubMed ID: 11846197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of Emdogain in periodontal and osseous regeneration].
    Sculean A; Rathe F; Junker R; Becker J; Schwarz F; Arweiler N
    Schweiz Monatsschr Zahnmed; 2007; 117(6):598-606. PubMed ID: 17691421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodontal regeneration with or without limited orthodontics for the treatment of 2- or 3-wall infrabony defects.
    Ogihara S; Wang HL
    J Periodontol; 2010 Dec; 81(12):1734-42. PubMed ID: 20629545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodontal regeneration with a combination of enamel matrix proteins and autogenous bone grafting.
    Cochran DL; Jones A; Heijl L; Mellonig JT; Schoolfield J; King GN
    J Periodontol; 2003 Sep; 74(9):1269-81. PubMed ID: 14584859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: a 24-month multicenter study.
    Francetti L; Trombelli L; Lombardo G; Guida L; Cafiero C; Roccuzzo M; Carusi G; Del Fabbro M
    Int J Periodontics Restorative Dent; 2005 Oct; 25(5):461-73. PubMed ID: 16250568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periodontal regeneration with enamel matrix derivative--case reports.
    Manor A
    J Int Acad Periodontol; 2000 Apr; 2(2):44-8. PubMed ID: 12666960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interest in periodontology and preferences for treatment of localized gingival recessions.
    Zaher CA; Hachem J; Puhan MA; Mombelli A
    J Clin Periodontol; 2005 Apr; 32(4):375-82. PubMed ID: 15811055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter study evaluating the sensitization potential of enamel matrix derivative after treatment of two infrabony defects.
    Froum S; Weinberg M; Novak J; Mailhot J; Mellonig J; Van Dyke T; McClain P; Papapanou PN; Childers G; Ciancio S; Blieden T; Polson A; Greenstein G; Yukna R; Wallace ML; Patters M; Wagener C
    J Periodontol; 2004 Jul; 75(7):1001-8. PubMed ID: 15341359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
    Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
    J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane.
    Iorio-Siciliano V; Andreuccetti G; Blasi A; Matarasso M; Sculean A; Salvi GE
    J Periodontol; 2014 Oct; 85(10):1342-50. PubMed ID: 24835417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
    Yilmaz S; Cakar G; Yildirim B; Sculean A
    J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects.
    Sculean A; Windisch P; Szendröi-Kiss D; Horváth A; Rosta P; Becker J; Gera I; Schwarz F
    J Periodontol; 2008 Oct; 79(10):1991-9. PubMed ID: 18834256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of localized intrabony periodontal defects with enamel matrix derivative (Emdogain). Case series].
    Szatmári P; Gera I
    Fogorv Sz; 2014 Mar; 107(1):15-28. PubMed ID: 24812749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
    Velasquez-Plata D; Scheyer ET; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
    Döri F; Arweiler N; Húszár T; Gera I; Miron RJ; Sculean A
    J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of an enamel matrix protein derivative on human teeth following periodontal surgery.
    Sculean A; Windisch P; Keglevich T; Fabi B; Lundgren E; Lyngstadaas PS
    Clin Oral Investig; 2002 Sep; 6(3):183-7. PubMed ID: 12271353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
    Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
    J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regenerative therapy of infrabony defects with or without systemic doxycycline. A randomized placebo-controlled trial.
    Röllke L; Schacher B; Wohlfeil M; Kim TS; Kaltschmitt J; Krieger J; Krigar DM; Reitmeir P; Eickholz P
    J Clin Periodontol; 2012 May; 39(5):448-56. PubMed ID: 22385260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.